Beijing Foyou Pharma CO.,LTD

¥15.69As of Sun 8 Nov 2026, 12:00 UTC
SSE:601089Healthcare
Country China
PE (Fwd) •••
TSR 4Y CAGR (4.04%)
Div yield 3.19%
ROE 9.82%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.14
PE TTM 19.47
TSR TTM (30.07%)
Mkt cap ¥7.343B
ROIC 19.88%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥16
2.08%
(63.09%)
Buy 5|6|5|2|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.21
0.21
0.23
0.22
19.25%
11.87%
11.70%
8.05%
Revenue¥M
343.6
336.7
327.7
324.0
8.98%
2.41%
(2.71%)
(3.13%)
Peers (US$1.101B)
Cap (US$)
PE
1.112B
54.61x
1.094B
—
1.085B
14.18x
Capital
TTM
5Y
10Y
Leveragex
0.372
0.068
0.052
EBIT/Intx
0.575
1.777
1.466
Own earn%
(13.26)
(29.97)
(41.18)
Sh yield%
23.67
16.14
14.21
Owners
Insiders/Inst%
11.55
34.26
Short interest%
5.50
SBC / revenue%
3.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
9–16
$1 testx
—
Incr. ROIC%
5